A recent study has demonstrated that Bcl-2 antagonist ABT-199 triggers apoptosis and augments ibrutinib-mediated cytotoxicity in CXCR4 wild type and CXCR4 WHIM mutated Waldenstrom macroglobulinemia cells [26]. This evidence concerns the gene CXCR4 and Waldenstrom macroglobulinemia.